ARTIVION, INC. Research and Development Asset Acquired Other than Through Business Combination, Written-off
ARTIVION, INC. (AORT) reported Research and Development Asset Acquired Other than Through Business Combination, Written-off of $3.51 million for the 12-month period ending 2010-12-31, per its 10-K filed 2013-02-15.
Discontinued › Expense Statement › Operating Expenses
us-gaap:ResearchAndDevelopmentAssetAcquiredOtherThanThroughBusinessCombinationWrittenOff · last filed 2013-02-15
- ARTIVION, INC. research and development asset acquired other than through business combination, written-off for the quarter ending 2010-12-31 was $0.00.
- ARTIVION, INC. research and development asset acquired other than through business combination, written-off for the quarter ending 2010-09-30 was $3.51M.
- ARTIVION, INC. research and development asset acquired other than through business combination, written-off for fiscal 2010 was $3.51M.
| Period end | Research and Development Asset Acquired Other than Through Business Combination, Written-off 3 month | Research and Development Asset Acquired Other than Through Business Combination, Written-off 6 month | Research and Development Asset Acquired Other than Through Business Combination, Written-off 9 month | Research and Development Asset Acquired Other than Through Business Combination, Written-off 12 month |
|---|---|---|---|---|
| 2010-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-15 | $3.51M derived: sum of 2 quarters · filed 2013-02-15 | $3.51M 10-K · filed 2013-02-15 | |
| 2010-09-30 | $3.51M 10-Q · filed 2011-10-27 | $3.51M 10-Q · filed 2011-10-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |
| Beta Bionics, Inc. (BBNX) | United States | $0.979B | -9.66 |
| SpyGlass Pharma, Inc. (SGP) | United States | $0.925B | |
| SI-BONE, Inc. (SIBN) | United States | $0.830B | -49.82 |
| Alphatec Holdings, Inc. (ATEC) | United States | $1.531B | -12.14 |
| KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) | United States | $1.535B | -9.02 |
| MIMEDX GROUP, INC. (MDXG) | United States | $0.687B | 89.92 |